Skip to main content

Table 4 Age ≥ 65 years: eGFR (CKD-EPI) and ACR category prevalence of CKD in T2DM a

From: Chronic kidney disease in US adults with type 2 diabetes: an updated national estimate of prevalence based on Kidney Disease: Improving Global Outcomes (KDIGO) staging

GFR category, ml/min/1.73 m2(CKD-EPI)

Albuminuria category, mg/g

< 30

30-300

> 300

Rowc

N

% (95% CI)

N

% (95% CI)

N

% (95% CI)

N

% (95% CI)

G1 ≥ 90

120b

6.0 (4.7-7.3)

54

3.2 (2.2-4.1)

7

0.2 (0.0-0.3)

181

9.4 (7.9-10.9)

G2 60-89

448b

33.0 (30.3-35.8)

187

11.5 (9.5-13.6)

51

3.1 (2.0-4.1)

686

47.6 (44.4-50.8)

G3a 45-59

197

14.8 (12.6-17.0)

111

7.5 (5.9-9.2)

35

2.2 (1.2-3.2)

343

24.5 (21.6-27.4)

G3b 30-44

69

5.6 (4.2%-7.0)

68

4.4 (3.2-5.7)

31

2.1 (1.0-3.3)

168

12.2 (10.0-14.4)

G4 15-29

19

1.4 (0.6-2.2)

28

2.7 (1.4-4.0)

29

2.0 (0.9-3.1)

76

6.1 (4.5-7.8)

G5 < 15

d

0.1 (-0.1-0.2)

d

0.0 (0.0-0.0)

10

0.2 (0.0-0.4)

12

0.3 (0.1-0.5)

Column N, % (95% CI) c

854

60.9 (58.2-63.7)

449

29.3 (26.4-32.2)

163

9.8 (7.5-12.0)

1466

100 (N/A)

  1. aAge adjusted to 2012 NHIS diabetes population.
  2. bDoes not meet CKD criteria based on eGFR or albuminuria.
  3. cSum of rows and columns may deviate due to rounding.
  4. dCell frequency suppressed when count < 3 to avoid potential identifiability and imprecision of estimates.
Back to article page

BMC Research Notes

ISSN: 1756-0500

Contact us